Influence sur les résultats des rebonds du PSA après curiethérapie de prostate : étude de 295 cas avec trois ans de suivi
Authors:
- A. ToledanoATA. Toledano
- L. ChauveincLCL. Chauveinc
- T. FlamTFT. Flam
- 1 May 2007
- journal article
- abstracts
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 11 (3) , 105-110
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- La curiethérapie du cancer prostatique: un état des lieux en 2004Oncologie, 2004
- Migration des grains d'iode 125 après curiethérapie prostatique : étude d'une série de 170 patientsCancer/Radiothérapie, 2004
- Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? a study of 450 patients by the Institut Curie/Hospital Cochin (Paris) GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- The temporal kinetics of PSA after 3D-conformal radiotherapy with androgen deprivationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Les indications de la curiethérapie de prostate par implantation permanenteCancer/Radiothérapie, 2002
- Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation TherapyJournal of Urology, 2002
- 10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- PROSTATE SPECIFIC ANTIGEN BOUNCE AFTER RADIOACTIVE SEED IMPLANTATION FOLLOWED BY EXTERNAL BEAM RADIATION FOR PROSTATE CANCERJournal of Urology, 2000
- Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic CarcinomaJournal of Urology, 1995